|
⚲
|
| Keyboard |
| Langdon Miller | |
|---|---|
| Firm | |
| Address | c/o Solve Therapeutics, Inc 1025 Alameda de Las Pulgas, Suite 122 Belmont, CA 94002 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Solve Therapeutics Inc | 021-564959 | Executive Officer | 48.2 M of 120.5 M |
||
| Solve Therapeutics Inc | 021-533368 | Executive Officer | 50.4 M of 75.6 M |
||
| Solve Therapeutics Inc | 021-430372 | Executive Officer | 63.5 M of 126.5 M |
||
| Velosbio Inc | 021-370879 | Executive Officer | 137.0 M of 137.0 M |
||
| Velosbio Inc | 021-323159 | Executive Officer | 59.3 M of 59.3 M |
||
| Oncternal Therapeutics Inc | 021-295508 | Executive Officer | 6.9 M of 11.3 M |
||
| Cleveland Biolabs Inc | 021-253747 | Executive Officer | 1.1 M of 1.1 M |
||
| Oncternal Therapeutics Inc | 021-245323 | Executive Officer | 17.9 M of 23.5 M |
||
| Calistoga Pharmaceuticals Inc | 021-144409 | Executive Officer | 25.0 M of 50.0 M |
||
| PTC Therapeutics Inc | 021-61608 | Executive Officer | 25.2 M of 50.3 M |
||
| Related People Network |
|---|
| Network #232 at Cleveland Biolabs Inc — files alongside 14 co-filers |
| Network #239 at PTC Therapeutics Inc — files alongside 11 co-filers |